Reports and Briefs on Therapy Area in South and Central America

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
Report
Report

The Vaccines Market Outlook to 2021

Strong growth expected in the vaccines market, as Sanofi Pasteur and Merck continue to dominate over the next 10 years.

Published By Datamonitor
13 Feb 2013 $2800
Buy
Report
Report

The Prostate Cancer Market Outlook to 2021

Recent approvals reinvigorate mCRPC market

Published By Datamonitor
18 Jan 2013 $2800
Buy
Report
Report

Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity

This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.

Published By Datamonitor
25 May 2010 $3800
Buy
Report
Report

Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) - Key differences in treatment despite standardized guidelines

Datamonitor's survey of 300 respiratory experts in Brazil, India, China and the US addresses increased interest in COPD in the emerging markets. The US is included as a benchmark, providing unique insight and comparisons of COPD market dynamics.

Published By Datamonitor
22 Dec 2010 $15200
Buy
Report
Report

Product Profiles of Leading Vaccines

Changing recommendations and crowded immunization schedules continue to impact key vaccine brands.

Published By Datamonitor
13 Feb 2013 $2800
Buy
Brief
Brief

Pre-Conference Review ACR ARHP

The ACR/ARHP 2012 Annual Meeting is being held in Washington, DC over November 9–14. Datamonitor has reviewed the abstracts and posters and discussed the conference with a prominent US rheumatologist, focusing onthe rheumatoid arthritis indication.

Published By Datamonitor
23 Oct 2012 $400
Buy
Report
Report

Pipeline: Colorectal Cancer

Developers look to other molecular targets to avoid direct competition

Published By Datamonitor
01 Feb 2013 $2800
Buy
Report
Report

Innovations in Ophthalmic Devices – Anterior Segment

Innovations in anterior segment ophthalmic devices will grow the market for presbyopia treatments and improve visual outcomes. They will also provide earlier diagnoses of dry eye and offer benefits in refractive and cataract surgery.

Published By Datamonitor
18 Oct 2012 $2800
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
24 Apr 2013 $2000
Buy
Report
Report

Drug Discovery for Rare Diseases

Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.

Published By Datamonitor
31 Aug 2012 $2800
Buy

« | 1 | 2 | » »|

No help is available.